HK1216432A1 - 製備 -二氧戊環核苷的方法 - Google Patents

製備 -二氧戊環核苷的方法

Info

Publication number
HK1216432A1
HK1216432A1 HK16104317.0A HK16104317A HK1216432A1 HK 1216432 A1 HK1216432 A1 HK 1216432A1 HK 16104317 A HK16104317 A HK 16104317A HK 1216432 A1 HK1216432 A1 HK 1216432A1
Authority
HK
Hong Kong
Prior art keywords
manufacture
methods
dioxolane nucleosides
nucleosides
dioxolane
Prior art date
Application number
HK16104317.0A
Other languages
English (en)
Inventor
Sznaidman Marcos
R Painter George
R Almond Merrick
G Cleary Darryl
Pesyan Amir
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory filed Critical Univ Emory
Publication of HK1216432A1 publication Critical patent/HK1216432A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK16104317.0A 2004-02-03 2016-04-15 製備 -二氧戊環核苷的方法 HK1216432A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54154504P 2004-02-03 2004-02-03

Publications (1)

Publication Number Publication Date
HK1216432A1 true HK1216432A1 (zh) 2016-11-11

Family

ID=34837503

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16104317.0A HK1216432A1 (zh) 2004-02-03 2016-04-15 製備 -二氧戊環核苷的方法

Country Status (9)

Country Link
US (2) US7785839B2 (zh)
EP (1) EP1720840B1 (zh)
KR (1) KR101157468B1 (zh)
CN (2) CN105039489A (zh)
BR (1) BRPI0507363A (zh)
CA (1) CA2554782C (zh)
ES (1) ES2568467T3 (zh)
HK (1) HK1216432A1 (zh)
WO (1) WO2005074654A2 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1467990B1 (en) * 2002-01-25 2012-03-07 Shire BioChem Inc. Process for producing dioxolane nucleoside analogue precursors
ES2568467T3 (es) * 2004-02-03 2016-04-29 Emory University Métodos para la fabricación de nucleósidos de 1,3-dioxolano
CN105385621B (zh) * 2015-11-20 2018-10-02 浙江昌明药业有限公司 琼氏不动杆菌zjutfet-1及其应用
WO2019245444A1 (en) 2018-06-21 2019-12-26 Medivir Ab Base-modified cytidine nucleotides for leukemia therapy

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684164A (en) 1988-04-11 1997-11-04 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
NZ228645A (en) 1988-04-11 1991-09-25 Iaf Biochem Int 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
US5041449A (en) 1988-04-11 1991-08-20 Iaf Biochem International, Inc. 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections
US5270315A (en) 1988-04-11 1993-12-14 Biochem Pharma Inc. 4-(purinyl bases)-substituted-1,3-dioxlanes
US6069252A (en) * 1990-02-01 2000-05-30 Emory University Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
US6642245B1 (en) * 1990-02-01 2003-11-04 Emory University Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
US5700937A (en) * 1990-02-01 1997-12-23 Emory University Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds
US5276151A (en) 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US6703396B1 (en) * 1990-02-01 2004-03-09 Emory University Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
US5179104A (en) 1990-12-05 1993-01-12 University Of Georgia Research Foundation, Inc. Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides
US5444063A (en) 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5925643A (en) 1990-12-05 1999-07-20 Emory University Enantiomerically pure β-D-dioxolane-nucleosides
ZA923640B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9311709D0 (en) 1993-06-07 1993-07-21 Iaf Biochem Int Stereoselective synthesis of nucleoside analogues using bicycle intermediate
JP3524606B2 (ja) * 1994-12-28 2004-05-10 三洋電機株式会社 固形製剤充填装置
GB9525606D0 (en) 1995-12-14 1996-02-14 Iaf Biochem Int Method and compositions for the synthesis of dioxolane nucleosides with › - configuration
US5792773A (en) 1996-11-15 1998-08-11 Yale University L-β-dioxolane uridine analog administration for treating Epstein-Barr virus infection
DE69823984T2 (de) * 1997-03-19 2005-05-12 University Of Georgia Research Foundation, Inc. Synthese, anti-hiv- und anti-hepatitis-b-virus-aktivitäten von 1,3-oxaselenolannukleosiden
RU2244712C2 (ru) 1998-08-12 2005-01-20 Гайлид Сайенсиз, Инк. Способ получения 1,3-оксатиоланового нуклеозида, способ получения производного 1,3-оксатиоланил-5-она
AP2001002207A0 (en) 1998-12-23 2001-09-30 Shire Biochem Inc Antiviral nucleoside analogues.
JP2002538780A (ja) 1999-02-11 2002-11-19 シェア バイオケム インコーポレーテッド ヌクレオシド類似体の立体選択的合成
US6512845B1 (en) * 1999-07-20 2003-01-28 Canon Kabushiki Kaisha Iterative approximation of color patch area
AU3144801A (en) 2000-02-11 2001-08-20 Shire Biochem Inc. Stereoselective synthesis of nucleoside analogues
MXPA03003278A (es) * 2000-10-13 2005-07-01 Shire Biochem Inc Analogos de dioxolano para suministro intercelular mejorado.
EP1467990B1 (en) 2002-01-25 2012-03-07 Shire BioChem Inc. Process for producing dioxolane nucleoside analogue precursors
IL166682A0 (en) 2002-08-06 2006-01-15 Pharmasset Ltd Processes for preparing 1,3-dioxolane nucleosides
ES2568467T3 (es) * 2004-02-03 2016-04-29 Emory University Métodos para la fabricación de nucleósidos de 1,3-dioxolano

Also Published As

Publication number Publication date
EP1720840A4 (en) 2009-01-21
CN101044122A (zh) 2007-09-26
CA2554782C (en) 2013-08-13
WO2005074654A3 (en) 2005-09-22
US20110130559A1 (en) 2011-06-02
EP1720840B1 (en) 2016-02-03
ES2568467T3 (es) 2016-04-29
US8420354B2 (en) 2013-04-16
KR20070085075A (ko) 2007-08-27
US7785839B2 (en) 2010-08-31
CN105039489A (zh) 2015-11-11
KR101157468B1 (ko) 2012-07-06
EP1720840A2 (en) 2006-11-15
US20060036092A1 (en) 2006-02-16
CA2554782A1 (en) 2005-08-18
WO2005074654A2 (en) 2005-08-18
BRPI0507363A (pt) 2007-07-03

Similar Documents

Publication Publication Date Title
GB2403475B (en) Stable integrands
GB0320283D0 (en) Improvements relating to lancets
EP1830858A4 (en) 3,6-BICYCLOLIDE
EP1927585A4 (en) PROCESS FOR OBTAINING 3,3-DIPHENYL PROPYLAMINES
HK1216432A1 (zh) 製備 -二氧戊環核苷的方法
EP1773157A4 (en) IMPROVEMENTS TO SHELVING
IL182538A0 (en) 1,5-diheterocycle-1h-triazole derivative
EP1723145A4 (en) SUBSTITUTED 5,12-DIAZENZOANTHRACENANALOGA
GB0400137D0 (en) Gyroscopically-stabilised bicycle
GB0425572D0 (en) 1,7-Naphthyridines
GB0415551D0 (en) Methods for producing pyrimidine nucleosides
GB0312539D0 (en) Improvements relating to gutters
AU304162S (en) Bicycle
GB0328694D0 (en) Improvement to tees
GB0424600D0 (en) Novel modified nucleosides
GB0407489D0 (en) Acetals
GB0302164D0 (en) Improvement to childs buggie
GB0420388D0 (en) Improvements relating to bicycles
GB0413163D0 (en) Improvements to signware
GB0411936D0 (en) 2 to 1
GB2441249B (en) Stable integrands
GB0326032D0 (en) Improvements relating to construction
GB0310624D0 (en) Acetals
GB0407712D0 (en) New phosphonate nucleosides
MXPA02003183A (es) Mejoras a juguete.